Oral antineoplastics in nononcology units: moving toward safer ordering, administration, and handling.

About 25% of all chemotherapy agents prescribed for patients with cancer are oral formulations. As a result, more patients in the acute care setting and tertiary care settings are receiving oral chemotherapy agents on nononcology units. This creates concerns about safe handling for patients, caregivers, and staff.